Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

246
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
246
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

488
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
488

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same journal

Long-Term Stable Wearable Electrochemical Aptamer Sensor for Cortisol in Artificial Sweat Based on a Gold Nanoparticle-Carboxymethyl Cellulose-Methylene Blue Interface.

ACS omega·2026
Same journal

From the Gut to the Brain: Modeling Intestinal Absorption and Assessing Blood-Brain-Barrier Permeability of Small-Molecule Drugs by IAM Chromatography.

ACS omega·2026
Same journal

Retraction of "Flexible Type Symmetric Supercapacitor Electrode Fabrication Using Phosphoric Acid-Activated Carbon Nanomaterials Derived from Cow Dung for Renewable Energy Applications".

ACS omega·2026
Same journal

A Green Magnetite-Coated Waste Biomass for Simultaneous Removal of Multiple Toxic Metals from Water.

ACS omega·2026
Same journal

Mechanically Stable Metal/Silica Antireflective and Antidust Coatings with Controlled Optical Properties to Mitigate Dust Adhesion in Desert Conditions.

ACS omega·2026
Same journal

A Molecular Analogue of Cu/ZSM‑5 Catalyzing the Monooxygenation of Hydrocarbons via a Mono μ‑Oxo Dicopper Species.

ACS omega·2026

相关实验视频

Updated: Jan 14, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K

H1-抗胰岛素的数学建模:使用拓指数的QSPR方法.

Merin Manuel1, Parthiban Angamuthu1

  • 1Department of Mathematics, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, Tamilnadu, India.

ACS omega
|October 27, 2025
PubMed
概括

定量结构-特性关系 (QSPR) 模型揭示了影响H1-抗组胺特性的关键分子因素. 这项研究有助于设计更安全,更有效的过敏药物.

科学领域:

  • 药用化学 医学化学
  • 计算化学计算化学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 过敏性疾病对全球健康构成重大挑战,需要改进治疗策略.
  • H1抗组胺药物对于治疗过敏症至关重要,但具有可变的特性,使最佳使用变得复杂.
  • 了解结构属性关系对于抗组胺药物开发中的合理药物设计至关重要.

研究的目的:

  • 研究H1抗组胺剂的定量结构-性质关系 (QSPR).
  • 为了将分子描述符与物理化学和药理动力学特性相关联.
  • 建立一个框架,以优化未来的抗组胺药物设计.

主要方法:

  • 利用基于度的拓索引进行分子表征.
  • 使用线性回归模型来建立QSPR.
  • 分析了一组不同的常规和第二代H1抗组胺药物.

主要成果:

  • 在拓指数和药物特性之间建立了强烈的,统计学上显著的相关性.
  • 确定了影响H1-抗组胺行为的关键分子因素.
  • 证明了拓描述符在药物设计中的预测能力.

结论:

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K

相关实验视频

Last Updated: Jan 14, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K
  • QSPR模型为H1-抗组胺分子行为提供了宝贵的见解.
  • 拓指数是预测药物特性的有效工具.
  • 这一框架可以加速下一代抗胰岛素药物的开发,这些抗胰岛素药物具有增强的特征.